Molecular Diagnostic Development
At PCR Biosystems we understand that every molecular diagnostic assay is different, and with this in mind we’ve developed a range of tailored reagents to support your work and overcome the challenges that can be faced during development.
Whether the focus is SARS-CoV-2 detection, freeze-dried multiplex assays or alternative amplification methods, you’ll be assured that our products are developed and extensively tested according to ISO 13485 standards. Our reagents undergo a comprehensive, multi-step quality control process, ensuring optimum performance, consistency and traceability whatever your molecular diagnostic assay.
In addition we offer bulk and custom supply, OEM manufacturing, and bespoke technical support to help you achieve the most from our market-leading enzymes and mixes.
PCR Biosystems is committed to providing researchers, developers and diagnostic kit manufacturers with the PCR products and services they need to detect SARS-CoV-2 and other viruses. The COVID-19 pandemic introduced…
Lyophilised and Air-Dried Assays
The development of molecular diagnostic tests is increasingly moving towards lyophilised (freeze-dried) and air-dried formats as these offer several advantages and cost savings. Whereas traditional ‘wet’ reagent formulations require cold…
Isothermal amplification encompasses nucleic acid amplification methods that take place at a single temperature and hence do not require thermal cycling. Such approaches utilise DNA polymerases with strong strand displacement…